158
Participants
Start Date
November 10, 2019
Primary Completion Date
February 10, 2022
Study Completion Date
February 10, 2022
Normal Saline along with standard treatment
PMZ-1620 (sovateltide) is an endothelin-B receptor agonist. PMZ-1620 has the potential to be a first-in-class neuronal progenitor cell therapeutics that is likely to promote quicker recovery and improve neurological outcome in cerebral ischemic stroke patients. In this arm normal saline along with standard treatment will be given for active comparison.
PMZ-1620 (sovateltide) along with standard treatment
PMZ-1620 (sovateltide) is an endothelin-B receptor agonist. PMZ-1620 has the potential to be a first-in-class neuronal progenitor cell therapeutics that is likely to promote quicker recovery and improve neurological outcome in cerebral ischemic stroke patients.
All India Institute of Medical Sciences, New Delhi
Indian Spinal Injury Centre, New Delhi
Dayanand Medical College & Hospital, Ludhiana
Department of Neurology, Christian Medical College and Hospital, Ludhiana
Sidhu Hospital Pvt. Ltd., Ludhiana
Post Graduate Institute of Medical Education and Research, Chandigarh
Pushpanjali Hospital & Research Centre Pvt. Ltd, Agra
Chopda Medicare & Research Centre, Nashik
New Era Hospital & Research Institute, Nagpur
Radiant Superspeciality Hospital, Amravati
Lalitha Superspecialities Hospital, Guntur
Lead Sponsor
Pharmazz, Inc.
INDUSTRY